Cite
HARVARD Citation
Papp, K. et al. (n.d.). Efficacy and safety of secukinumab in the treatment of moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled phase II dose‐ranging study. British journal of dermatology. pp. 412-421. [Online].